SCP
BIIB icon

Sender Company & Partners’s Biogen BIIB Stock Holding History

Sender Company & Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,796
Closed -$499K – 21
2023
Q1 		$499K Buy
1,796
+896
+100% +$248K 0.53% 20
2022
Q4 		$249K Sell
900
-6
-0.7% -$1.7K 0.33% 42
2022
Q3 		$242K Buy
+906
New +$192K 0.59% 36

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Sender Company & Partners's BIIB Position: Q2 2023 in Review

Sender Company & Partners sold out of Biogen (BIIB) in Q2 2023, closing a stake of 1,796 shares — an estimated $499K sold.

Sender Company & Partners first reported a position in BIIB in Q3 2022 and held it in 3 quarters. The position peaked at $499K in Q1 2023. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • Sender Company & Partners reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
  • Sender Company & Partners sold 1,796 Biogen shares in Q2 2023, an estimated $499K.
  • Sender Company & Partners first reported a position in Biogen in Q3 2022 and held it in 3 quarters.
  • Sender Company & Partners's Biogen position peaked at $499K in Q1 2023.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Sender Company & Partners's 13F filing for Q2 2023, filed 14 Aug 2023.